LLLijian Mm Liu

Lijian Mm Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lijian Mm Liu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Causal relationships between antibody-induced immune responses and sepsis: Evidence from genetic studies

    by Liqun Li, Lijian Liu, Jing Yan, Jinjing Tan, Sheng Xie

    The causal relationships between antibody-induced immune responses and the occurrence and mortality of sepsis remain controversial. The 2-sample Mendelian randomization (MR) approach was utilized to reveal the causal associations, along with the potential mediation effects of inflammatory cytokines. The causal associations were analyzed by a 2-sample bidirectional MR analysis, primarily using the inverse variance weighted method. MR-Egger regression, weighted mode, weighted median, and simple mode were conducted as supplementary analyses. Additionally, we performed a 2-step MR to investigate the potential mediation effects of 91 inflammatory cytokines. Cochran Q test was conducted to assess statistical heterogeneity. Potential horizontal pleiotropy was identified with MR-Egger regression intercept test and MR-pleiotropy residual sum and outlier global test. Leave-one-out sensitivity analysis was employed to evaluate the influence of an individual single nucleotide polymorphism on the estimates. The outcomes revealed positive associations between genetically predicted Helicobacter pylori urea antibody levels (odds ratios [ORs] = 1.070, 95% confidence interval [CI]: 1.009–1.134, P = .024), anti-herpes simplex virus type 1 immunoglobulin G seropositivity [OR = 1.071, 95% CI: 1.012–1.134, P = .018], and the risk of sepsis; cytomegalovirus phosphoprotein 52 antibody levels showed significant negative correlation with 28-day mortality in sepsis [OR = 0.830, 95% CI: 0.690–0.999, P = .048]. Surprisingly, the mediation analysis suggested that the 91 inflammatory cytokines did not mediate these associations. H pylori urea antibody and anti-herpes simplex virus type 1 immunoglobulin G seropositivity are pathogenic factors for sepsis, while cytomegalovirus phosphoprotein 52 antibody levels may protect against 28-day mortality in sepsis. Inflammatory cytokines may not mediate these relationships. These findings could contribute to the precise management of sepsis.

  • Open Access

    Association between antibody-mediated immune responses and gastroesophageal reflux disease: Evidence from genetic studies

    by Liqun Mm Li, Lijian Mm Liu, JinJing Tan, Hongxia Bs Pan, Chengning Mm Yang, Jieru Mm Xie, Jing Mm Yan, Jinchan Bs Peng, Xiaoyan Huang, Sheng Mm Xie

    Studies have proven an association between the specific antibody-mediated immune response and gastroesophageal reflux disease (GERD); however, the exact causal associations remain unclear. Our research aims to evaluate the causal relationships between the genetic susceptibility to 46 antibody-mediated immune responses and GERD, with the bidirectional two-sample Mendelian randomization (TSMR) and to explore the mediating effects of 91 circulating inflammatory cytokines by a two-step MR analysis. Multiple MR analysis methods, including inverse variance weighted, MR-Egger, weighted mode, weighted median, simple mode, and MR pleiotropy residual sum and outlier, were employed for the bidirectional TSMR analysis. Besides, sensitivity analyses, such as Cochran Q statistics, MR-Egger intercept, MR pleiotropy residual sum and outlier global test, and the leave-one-out method were implemented to identify potential heterogeneity and pleiotropy. In the forward MR analysis, the inverse variance weighted method demonstrated that anti-cytomegalovirus (anti-CMV) IgG seropositivity (OR = 1.031, 95% CI: 1.000–1.062, P = .048), levels of human herpes virus (HHV) 7 U14 antibody (OR = 1.097, 95% CI: 1.032–1.167, P = .003), and herpes simplex virus 1 (HSV-1) mgG-1 antibody (OR = 1.069, 95% CI: 1.020–1.119, P = .005), which have higher genetic prediction, are positively related to GERD risks. Reverse MR analysis revealed GERD increased the level of Epstein–Barr virus VCA p18 antibody (OR = 1.255, 95% CI: 1.028–1.533, P = .026), while decreased the anti-CMV IgG seropositivity (OR = 0.663, 95% CI: 0.444–0.991, P = .045) and HHV 7 U14 antibody level (OR = 0.777, 95% CI: 0.630–0.958, P = .018) as well. Besides, other antibodies, including anti-Helicobacter pylori (H pylori) IgG, H pylori CagA, and H pylori VacA demonstrated no correlations (neither positive nor negative) with GERD risks. Surprisingly, TSMR showed that 91 cytokines seemed not to mediate HSV-1 mgG-1 to enhance GERD risks. The research provided convincing evidence for establishing a causal relationship between antibody-mediated immune responses and GERD, proving that genetic-prediction-based HSV-1 mgG-1 could increase GERD risk and that inflammatory factors may not be involved in mediating this association. Besides, GERD was found to reduce Epstein–Barr virus VCA p18 antibody. Moreover, we revealed the bidirectional causal relationships between GERD and the antibodies, including anti-CMV IgG, HHV 7 U14. This research may contribute to a better understanding of the mechanism that triggers GERD, also emphasizing the clinical potential of therapeutic interventions targeting antibody-mediated immune responses.

  • Open Access

    Causal relationships between 91 inflammatory cytokines and gastroesophageal reflux disease, and the mediating role of related metabolites: Evidence from genetics

    by Liqun Mm Li, Lijian Mm Liu, Jieru Mm Xie, Chengning Mm Yang, Guangwen Mm Chen, Jinjing Tan, Xiaoyan Huang, Sheng Mm Xie

    The associations between specific inflammatory cytokines and gastroesophageal reflux disease (GERD) have been confirmed, while their causal relationships remain unclear. We conducted a bidirectional 2-sample Mendelian randomization analysis (MRA) to reveal the causal correlations between 91 inflammatory factors and GERD, thereby conducting a 2-step MRA analysis to reveal the mediating function of 1400 metabolites therein. Data related to 91 inflammatory cytokines were derived from Genome-Wide Association Studies (GWAS) data with 14,824 samples. GWAS data about GERD were obtained from a large genome research project in Finland, including 28,859 GERD cases and 3,50,064 controls. GWAS data about 1400 circulating metabolites were derived from a cohort of 8299 individuals. The inverse variance weighted approach was introduced to obtain the primary MRA results, complemented by 4 additional methods for supportive analyses. Additionally, the study conducted sensitivity analyses with different methods to evaluate heterogeneity and horizontal pleiotropy. Our findings indicated that higher predicted C-X-C motif chemokine 1 [OR = 1.052, 95% CI: 1.004 − 1.103, P = .035], interleukin-1-alpha [OR = 1.083, 95% CI: 1.018 − 1.152, P = .012], and interleukin-4 [IL-4, OR = 1.081, 95% CI: 1.018 − 1.147, P = .011] increased the risk of GERD; whereas tumor necrosis factor ligand superfamily member 12 [OR = 0.958, 95% CI: 0.9174–0.9999, P = .0493] decreased the risk of GERD. No significant statistical differences were found for other inflammatory cytokines. Genetic susceptibility to GERD had no impact on any traits related to circulating inflammatory cytokines. Four metabolites associated with elevated IL-4 levels were identified, including (1-enyl-oleoyl)-GPE (P-18:1), 4-methyl guaiacol sulfate, X-12730, and X-17685, but their mediating effects were not statistically significant (P > .05). This study convincingly proved the causal impact of inflammatory factors on GERD. It confirms that C-X-C motif chemokine 1, interleukin-1-alpha, and IL-4 increase the risk of GERD, while tumor necrosis factor ligand superfamily member 12 reduces it. Additionally, several circulating metabolites are associated with elevated IL-4 levels. However, the evidence for their role as potential mediators in the pathway between IL-4 and GERD risk remains insufficient. The findings of this study propel further comprehension of the pathogenesis of GERD and also point out the therapeutic potential for interventions targeting inflammatory cytokine-targeted inventions.

  • Open Access

    Common bile duct stump stones and recurrent acute pancreatitis after Roux-en-Y choledochojejunostomy in a child: A case report

    by Jian-Feng Li, Min-Jian Xie, Jin-Xiu Wei, Cheng-Ning Yang, Guang-Wen Chen, Li-Qun Li, Yi-Na Zhao, Li-Jian Liu, Sheng Xie

    BACKGROUND Pancreaticobiliary maljunction (PBM) is a rare congenital abnormality in pancreaticobiliary duct development. PBM is commonly found in children, and it often leads to acute pancreatitis and other diseases as a result of pancreaticobiliary reflux. Roux-en-Y choledochojejunostomy is a common surgical method for the treatment of PBM, but there are several associated complications that may occur after this operation. CASE SUMMARY The patient, a 12-year-old female, was hospitalized nearly 20 times in 2021 for recurrent acute pancreatitis. In 2022, she was diagnosed with PBM and underwent laparoscopic common bile duct resection and Roux-en-Y choledochojejunostomy in a tertiary hospital. In the first year after surgery, the patient had more than 10 recurrent acute pancreatitis episodes. After undergoing abdominal computed tomography and other examinations, she was diagnosed with “residual bile duct stones and recurrent acute pancreatitis”. On January 30, 2024, the patient was admitted to our hospital due to recurrent upper abdominal pain and was cured through endoscopic retrograde cholangiopancreatography. CONCLUSION This article reports a case of a child with distal residual common bile duct stones and recurrent acute pancreatitis after Roux-en-Y choledochojejunostomy for PBM. The patient was cured through endoscopic retrograde cholangiopancreatography.


  • Open Access

    Association of MCP-4, NRTN, and PD-L1 with the risk of hepatic fibrosis: A Mendelian randomization study

    by Liqun Mm Li, Jing Mm Yan, Qian Bs Liu, Laian Ge, Yifeng Mm Pan, Bingjie Bs Han, Chunmei Bs Wang, Xiaomei Bs Tang, Lijian Mm Liu, Sheng Mm Xie

    Previous studies have confirmed the affiliation between specific inflammatory cytokines and Hepatic fibrosis (HF); however, contradictions remain in the causality. The study implemented a bidirectional two-sample Mendelian randomization (MR) analysis with published statistics derived from Genome-wide Association Studies (GWAS) to investigate casualties between inflammatory cytokines and HF. Additionally, MR analysis was also introduced to consider if 1400 blood metabolites act as the key mediators in this process. Single nucleotide polymorphisms (SNPs) with strong correlations to inflammatory factors were selected for multiple MR analyses in this study. The inverse variance weighted method (IVW) was chosen as the principal analysis, and the others as the supportive. Besides, sensitivity tests were involved to identify potential heterogeneity and pleiotropic level. IVW methods revealed that a relatively high level of prediction-based monocyte chemoattractant protein-4 (MCP-4) (95% CI: 1.014–3.336, P = .045), along with neurturin (NRTN) (95% CI: 1.204–4.004, P = .010), may increase the risk of HF; while programmed cell death 1 ligand 1 (PD-L1) (95% CI: 0.223–0.928, P = .030), showed a protective effect on HF. No significant statistical differences were detected on any other inflammatory cytokines, nor did the impact of HF genetic predisposition on the 91 circulating inflammatory cytokines-related characteristics.